Jeena Sikho Lifecare Limited has announced the publication of a case study and a research article in the European Journal of Pharmaceutical and Medical Research and the International Journal of Advanced Research (IJAR), respectively. These publications were authored by medical professionals associated with the company, including its Managing Director, senior consultants, and Ayurvedic experts. The case study, titled "Ayurvedic Management of Type 2 Diabetes Mellitus: A Case Study," details the successful treatment of a 45-year-old female patient with Type 2 Diabetes Mellitus (T2DM), characterized by low fecal pancreatic elastase and high cholesterol levels. The research article focuses on "Integrative Hope in Advanced Chronic Kidney Disease: An Ayurvedic Case Approach."

The case study highlights the effectiveness of a personalized Ayurvedic treatment regimen, which included dietary modifications, lifestyle recommendations, and specific medicinal interventions. Following a three-month treatment, the patient showed significant clinical improvement, with reduced blood glucose levels, normalized HbA1c, improved fecal elastase, and stabilized lipid profiles. The company states these publications underscore its commitment to advancing Ayurvedic research and promoting evidence-based clinical practices.

The case study details the patient's condition before and after treatment, showing alleviation of generalized weakness and improved appetite. Blood glucose levels reduced from 159 mg/dl to 129 mg/dl, and HbA1c decreased from 7.3% to 6.4%. Fecal elastase improved from 102 µg/g to 694 µg/g, and cholesterol levels normalized. The authors emphasize the potential of Ayurvedic interventions as supportive strategies in the comprehensive management of T2DM with associated pancreatic insufficiency and dyslipidemia, suggesting further large-scale trials.